Epilepsy & Seizure
Online ISSN : 1882-5567
ISSN-L : 1882-5567
最新号
選択された号の論文の9件中1~9を表示しています
Original Article
  • Takato Morioka, Fumihito Mugita, Satoshi Inoha, Tomoaki Akiyama, Hiron ...
    2025 年17 巻 論文ID: A000162
    発行日: 2025年
    公開日: 2025/01/27
    ジャーナル フリー HTML

    Background: The 2021 version of the Standardized Critical Care EEG Terminology published by the American Clinical Neurophysiology Society (ACNS 2021) specifies the diagnostic criteria for non-convulsive status epilepticus (NCSE) using continuous electroencephalographic (cEEG) monitoring. Since few facilities have access to cEEG, routine EEG, which can only be performed during consultation hours, is generally used for emergencies. We examined if the diagnostic ability is enhanced by adding arterial spin labeling (ASL) perfusion imaging to 1.5-Tesla magnetic resonance imaging (MRI). Patients and Methods: Eighty EEGs, performed on patients with neurological emergencies for 2 years, were reviewed which included three patients diagnosed with electrographic seizures (ESz). Results: Based on the ACNS21, EEG could diagnose Esz, but could not diagnose NCSE, being a 30-minute recording. In contrast, ASL clearly identified focal, ictal hyperperfusion. The signal intensity was maximized at a post-labeling delay (PLD) of 1.5-1.75 s. The signal intensity gradually decreased. However, even at a PLD of 2.0 s, the intensity remained strong in areas with a close anatomical relationship to the epileptogenic lesions. Further, the same region showed high signal intensity on diffusion-weighted imaging (DWI). Conclusion: Although ESz can be diagnosed based on the ACNS 2021 using EEG alone, diagnosing NCSE can be challenging. Therefore, our suggestion is to initially perform MRI to capture the hemodynamics of ictal hyperperfusion using ASL with multiple PLDs, and monitor the coupling state of metabolism and blood flow with DWI. Finally, an accurate pathophysiological diagnosis of NCSE should be confirmed by EEG.

  • Takato Morioka, Fumihito Mugita, Satoshi Inoha, Takafumi Shimogawa, No ...
    2025 年17 巻 論文ID: A000163
    発行日: 2025年
    公開日: 2025/02/04
    ジャーナル フリー HTML

    Background: We evaluated the usefulness of capturing periictal hyperperfusion for the pathophysiological diagnosis of acute symptomatic seizures (ASS) using 1.5-Tesla (T) arterial spin labeling (ASL) perfusion images and examined the relationship between the time from ASS cessation to ASL imaging and the visualization of periictal hyperperfusion.Patients & Methods: In four patients who presented short ASS, we retrospectively analyzed the performance status and findings of 1.5-T ASL with triple post-labeling delays (PLDs) of 1.5, 1.75 and 2.0 s, as well as routine electroencephalography (EEG).Results: In two patients where ASL imaging was performed 1 or 9 h after ASS, periictal ASL hyperperfusion was markedly visualized. In one patient where images were taken 11 h later, fairly good visualization was obtained. The increase in signal intensity peaked at a PLD of 1.5 s and gradually attenuated with PLDs of 1.75 and 2.0 s. However, the areas where the signal remained intense even at a PLD of 2.0 s had a strong anatomical relationship with the lesion. No clear periictal hyperperfusion was visualized on ASL images taken 13 h later. Although paroxysmal discharges were recorded in one patient where EEG was performed 40 min after ASS, no paroxysms were detected in the other three patients whose EEG was recorded 8 h to 2 days later.Conclusion: We consider it appropriate to first perform ASL within 11 h, and then verify the results with subsequent EEG to accurately diagnose the pathophysiology of ASS.

  • Fumihito Mugita, Takato Morioka, Satoshi Inoha, Hiroshi Oketani, Tomoa ...
    2025 年17 巻 論文ID: A000166
    発行日: 2025年
    公開日: 2025/06/20
    ジャーナル フリー HTML

    Purpose: The mechanism underlying sulcal hyperintensity observed on fluid-attenuated inversion recovery magnetic resonance imaging (MRI) (sulcal FLAIR hyperintensity [S-FLAIR-HI]) without apparent abnormalities in the cerebrospinal fluid (CSF) is believed to involve alterations in regional hemodynamics, including venous congestion caused by mass effect, leading to a pathological increase in the blood pool-to-CSF ​​ratio. While S-FLAIR-HI is observed in chronic subdural hematoma (CSDH), its exact incidence, mechanism of occurrence, and relationship with seizures remain unclear.

    Methods: Clinical data and MRI findings, including FLAIR and 1.5-Tesla pseudo-continuous arterial spin labeling perfusion imaging performed within 1 day before surgery in 34 patients with CSDH, were retrospectively reviewed. The focus was on the laterality of arterial transit artifact(s) in the sulcus (sulcal ATA [S-ATA]), which are intravascular signals that increase with a delay in arterial transit time, and (peri-)ictal hyperperfusion linked to seizure activity by neurovascular coupling.

    Results: S-FLAIR-HI was observed in 12 (35.3%) of the 34 patients with CSDH, 11 of whom exhibited an increase in S-ATA on the ipsilateral side. Increased S-ATA levels were also observed in 10 of the 22 patients without S-FLAIR-HI. However, none of the 12 patients with S-FLAIR-HI developed seizures. In addition, 2 patients who exhibited perioperative seizures did not undergo S-FLAIR-HI.

    Discussion: S-FLAIR-HI, observed preoperatively in approximately one-third of patients with CSDH, is a nonspecific finding caused by alterations in regional hemodynamics. Furthermore, there is no evidence supporting the direct involvement of S-FLAIR-HI in the development of seizures.

  • Rahma Maalej, Abir Hadriche, Nawel Jmail
    2025 年17 巻 論文ID: A000170
    発行日: 2025年
    公開日: 2025/11/12
    ジャーナル フリー HTML

    Purpose: High-frequency oscillations (HFOs) in intracranial electroencephalography (iEEG) are widely investigated as potential biomarkers of epileptogenic tissue. This study aims to propose and evaluate a hybrid deep learning model that combines convolutional neural networks (CNNs) and Transformer architectures for the automatic classification of five types of synthetic iEEG events. Methods: A simulation-based dataset was generated following the framework of Jmail et al. and subsequently processed through preprocessing and data augmentation procedures. The dataset includes five representative event classes: spikes, ripples (80–250 Hz), fast ripples (250–500 Hz), spike–ripple superimposed events, and artifacts. The signals were created under controlled variations of amplitude, oscillation frequency, signal-to-noise ratio (SNR), and overlap rate, providing a reproducible environment for methodological evaluation. Results: The proposed hybrid CNN–Transformer model demonstrated robust discrimination performance across all five classes, achieving an overall accuracy of 97.7%. The model leverages CNN-based spatial–spectral feature extraction and Transformer-based temporal–contextual modeling, enabling effective capture of both local and global signal dependencies. Discussion: Although the simulated frequency range extends beyond the theoretical Nyquist limit of typical EEG recordings, this design intentionally tests model robustness under extended spectral conditions. This proof-of-concept study provides a reproducible and controlled assessment of hybrid attention-based architectures for HFO recognition and establishes a foundation for future validation using real iEEG recordings.

  • Yuichi Kubota, Satomi Nakagawa, Chika Kondo, Satoshi Takemoto
    2025 年17 巻 論文ID: A000169
    発行日: 2025年
    公開日: 2025/11/29
    ジャーナル フリー HTML

    Purpose: In Japan, intravenous (IV) midazolam (MDL) is recommended as first-line therapy for pediatric patients with status epilepticus (SE) if venous access is possible. However, few studies have investigated its use in adults/adolescents with SE. This prospective, uncontrolled, open-label study investigated the efficacy and safety of bolus or continuous IV MDL in adults/adolescents with convulsive SE.Methods: Patients aged ≥15 years who satisfied the diagnostic criteria for SE with convulsive seizures lasting ≥5 min were enrolled. Patients first received bolus IV MDL (0.15 mg/kg). If the seizures continued, additional doses (0.1‒0.3 mg/kg) were administered (maximum cumulative dose: 0.6mg/kg). Patients with a high likelihood of recurrent convulsive seizures were subsequently administered continuous IV MDL (0.1 mg/kg/h). The dose was increased until seizure cessation (maximum: 0.4 mg/kg/h) and administration continued for 24 h from seizure cessation. The primary efficacy endpoint was convulsive seizure cessation after bolus IV. Safety endpoints included adverse events (AEs) and adverse drug reactions (ADRs).Results: Twenty-one patients (aged 18.0‒89.0 years) with SE were enrolled. The convulsive seizure cessation rate after bolus IV MDL was 100.0% (21/21 patients), which was statistically significant (P < 0.001) in one-sample testing (binomial distribution). The most common AE/ADR was hypotension (four patients [19.0%]). There were no deaths, serious AEs/ADRs, or AEs/ADRs leading to discontinuation of MDL. Respiratory depression occurred in two patients (9.5%). None of the patients required mechanical ventilation/endotracheal intubation.Discussion: Bolus IV MDL achieved a high seizure cessation rate in patients with convulsive SE, with minimal effects on respiratory or cardiovascular functions and no major safety issues.

Mini Review
Brief Communication
Critical Review
feedback
Top